


Searching News Database: Noona
HSMN NewsFeed - 6 Nov 2019
Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Care
Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Care
HSMN NewsFeed - 3 Mar 2010
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
HSMN NewsFeed - 6 Oct 2008
Terrence A. Noonan Named Endocare Interim President and Interim Chief Executive Officer
Terrence A. Noonan Named Endocare Interim President and Interim Chief Executive Officer
HSMN NewsFeed - 4 Jun 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
HSMN NewsFeed - 5 Oct 2007
Helixis, Inc. Announces Advanced Technology Ventures' Role in Series A Financing
Helixis, Inc. Announces Advanced Technology Ventures' Role in Series A Financing
HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
HSMN NewsFeed - 14 Mar 2007
Napo Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment
Napo Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment
Additional items found! 28
Members Archive contains
28 additional stories matching:
Noona
(Password required)
Noona
(Password required)
